INTRODUCTION
Chronic Kidney Disease (CKD) is defined as abnormalities of kidney structure or function, present for more than 3 months, with implications for health. Kidney damage refers to a broad range of abnormalities of kidney resulting in decline of excretory, endocrine and metabolic functions. KDIGO refers to a eGFR<60 ml/min/1.73m 2 as decreased eGFRand eGFR<15 ml/ min/1.73m 2 as kidney failure. 1 Hyperuricemia is defined as serum uric acid more than 7 mg/dl in males and 6 mg/dl in females. 2 Chronic hyperuricemia is strongly associated with chronic tubulointerstital disease and decreased renal function. 3, 4 Evidence reported on an association of uric acid with hypertension and renal disease. 5 It is
Free Full Text Articles are Available at www.jnma.com.np a potent antioxidant outside cell, pro-oxidant inside cell and induce stimulation of NADPH oxidases with mitochondrial dysfunction. 6 It leads to arteriosclerosis, glomerular hypertension and glomerulosclerosis and progress CKD. 7 This study is done to know the prevalence of high serum uric acid level in chronic renal disease and to correlate between severity of the renal disease and serum uric acid level.
METHODS
It is a hospital based cross-sectional study. Where n= required sample size Zα= z deviated corresponding to desired reliability level (1.96) P= estimated proportion in the population (10.6%) 8 Q= 100-P (if P is in %) d = maximum tolerable error (10%) CKD staging is done as following (Table 1 ) . A detailed clinical history was recorded from the patients in the predesigned proforma. Data relating to demographic profile including age, gender, residence, occupation were recorded. Presenting features along with duration, history of smoking, alcohol consumption significant past history of diabetes mellitus (DM), hypertension and treatment were recorded. A thorough clinical examination was done and vitals-blood pressure and pulse rate, height, weight and relevant systemic examination. Then routine laboratory tests for CKD such as complete blood count, blood sugar, urea, creatinine, sodium, potassium, calcium, phosphorus, total protein, albumin, urine analysis, abdominal ultrasonogram, and electrocardiogram were performed and after confirming diagnosis of CKD with staging, blood sample for UA was sent. 
RESULTS
Out of 57 patients, 38 were male and 19 were female. The mean age for the total number of patients was 51.63 years. Hyperuricemia was present in 55 (96.49%) of the patients (Figure 1 ).
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Hyperuricemia
The mean uric acid level in men was 9.38±1.403 mg/ Of the study population 15 (26.31%) had hypertension, 6 (10.52%) had hypertension and DM, 18 (31.6%) had hypertension and smoking, 2 (3.5%) had DM, 9 (15.8%) had hypertension, DM and smoking and 2 (3.5%) were only smokers ( Figure 4 ). 
DISCUSSION
This study has evaluated prevalence of hyperuricemia in Chronic Kidney Disease. Patients in a cohort of 57 subjects, out of which 38 patients (66.7%) were male and 19 patients (33.3%) were females. In this study, hyperuricemia was present in 96.49% of study population while 3.51% has normal serum uric acid. The mean serum uric acid in the study population was 9.213 mg/dl. Similar study done by Jolly ES et al. in which a 1078 participants was analysed in Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study in which the participants were followed for 4 years. Sixty three (13%) of the participants had CKD. The mean age of the participants having CKD was 63 years. Forty seven (63%) of them had HTN and 7 (9%) had DM. BMI of the CKD patients was 28.5 kg/m 2 . The mean serum uric acid of the study participants was 6.5±1.9 mg/dl. 9 In the study done by Paudel YP et Most of the patients in our study were hypertensive, so it can be concluded that hyperuricemia may lead to the progession of CKD faster in hypertensive patients. Study done by Sedaghat S et al. in a prospective cohort showed that high levels of serum uric acid are associated with faster decline in eGFR and increased incidence of CKD. 12 The association was more pronounced in hypertensive subjects compared to normotensive individuals. In this study the most common cause for CKD was hypertension 57.89% of studied population had HTN. Hypertension and DM both were present on 27.31% of the patient. DM alone was present on 3.5% of the patients. The remaining 12.28% of the patient had other causes for CKD. In the study done by Adejumo OA et al. involving 120 patients the causes of CKD were that 37.8% of the patient had hypertensive nephropathy, 30% had diabetic nephropathy, 27.5% had chronic glomerulonephritis and 5.8% had other causes for CKD.
CONCLUSIONS
This study showed that hyperuricemia is highly prevalent among CKD patients with conservative management. Though this study showed increasing prevalence of hyperuricemia with increasing stage of CKD (stage III to V), the mean value of uric acid did not show significant difference among different stages. Further studies without above mentioned limitation and including larger group are needed.
